Zentiva Group has expanded the footprint of its manufacturing network after acquiring a manufacturing site in Ankleshwar, India from Sanofi.
“Expanding our network of Zentiva’s wholly-owned manufacturing sites is a key factor in our future success, ensuring greater security of supply for people living in Europe and beyond. It enables us to innovate further to achieve operational excellence, enhance productivity and accelerate growth,” said Nick Haggar, CEO of Zentiva.
“We are strongly committed to the growth and success of the Ankleshwar team and operations. The site will be the largest in our network and the team in India will play a central role in the operations of Zentiva.”
With demand for high quality and affordable medicines increasing, the acquisition reaffirms Zentiva’s commitment to stand side-by-side with pharmacists, healthcare professionals and decision makers in improving access for patients.